329 related articles for article (PubMed ID: 10987269)
1. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.
Birner P; Schindl M; Obermair A; Plank C; Breitenecker G; Oberhuber G
Cancer Res; 2000 Sep; 60(17):4693-6. PubMed ID: 10987269
[TBL] [Abstract][Full Text] [Related]
2. Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy.
Burri P; Djonov V; Aebersold DM; Lindel K; Studer U; Altermatt HJ; Mazzucchelli L; Greiner RH; Gruber G
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):494-501. PubMed ID: 12738326
[TBL] [Abstract][Full Text] [Related]
3. Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.
Birner P; Gatterbauer B; Oberhuber G; Schindl M; Rössler K; Prodinger A; Budka H; Hainfellner JA
Cancer; 2001 Jul; 92(1):165-71. PubMed ID: 11443623
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: a clinicopathologic study and a meta-analysis.
Huang M; Chen Q; Xiao J; Yao T; Bian L; Liu C; Lin Z
Int J Gynecol Cancer; 2014 Jul; 24(6):1054-64. PubMed ID: 24978711
[TBL] [Abstract][Full Text] [Related]
5. DNA repair-redox enzyme apurinic endonuclease in cervical cancer: evaluation of redox control of HIF-1alpha and prognostic significance.
Schindl M; Oberhuber G; Pichlbauer EG; Obermair A; Birner P; Kelley MR
Int J Oncol; 2001 Oct; 19(4):799-802. PubMed ID: 11562758
[TBL] [Abstract][Full Text] [Related]
6. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.
Bachtiary B; Schindl M; Pötter R; Dreier B; Knocke TH; Hainfellner JA; Horvat R; Birner P
Clin Cancer Res; 2003 Jun; 9(6):2234-40. PubMed ID: 12796391
[TBL] [Abstract][Full Text] [Related]
8. Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry.
Kim BW; Cho H; Chung JY; Conway C; Ylaya K; Kim JH; Hewitt SM
J Transl Med; 2013 Aug; 11():185. PubMed ID: 23927384
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor and hypoxia inducible factor-1alpha in cervical neoplasia.
No JH; Jo H; Kim SH; Park IA; Kang D; Han SS; Kim JW; Park NH; Kang SB; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():105-10. PubMed ID: 19723043
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Gruber G; Greiner RH; Hlushchuk R; Aebersold DM; Altermatt HJ; Berclaz G; Djonov V
Breast Cancer Res; 2004; 6(3):R191-8. PubMed ID: 15084243
[TBL] [Abstract][Full Text] [Related]
11. How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer?
Cheng Y; Chen G; Hong L; Zhou L; Hu M; Li B; Huang J; Xia L; Li C
Ann Diagn Pathol; 2013 Jun; 17(3):305-11. PubMed ID: 23375385
[TBL] [Abstract][Full Text] [Related]
12. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
[TBL] [Abstract][Full Text] [Related]
13. Plausible linkage of hypoxia inducible factor-1alpha in uterine cervical cancer.
Fujimoto J; Alam SM; Jahan I; Sato E; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Cancer Sci; 2006 Sep; 97(9):861-7. PubMed ID: 16805819
[TBL] [Abstract][Full Text] [Related]
14. Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma.
Matsuyama T; Nakanishi K; Hayashi T; Yoshizumi Y; Aiko S; Sugiura Y; Tanimoto T; Uenoyama M; Ozeki Y; Maehara T
Cancer Sci; 2005 Mar; 96(3):176-82. PubMed ID: 15771621
[TBL] [Abstract][Full Text] [Related]
15. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
[TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.
Birner P; Schindl M; Obermair A; Breitenecker G; Oberhuber G
Clin Cancer Res; 2001 Jun; 7(6):1661-8. PubMed ID: 11410504
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
18. Elevated expression of thymosin β4, vascular endothelial growth factor (VEGF), and hypoxia inducible factor (HIF)-1α in early-stage cervical cancers.
Kim NS; Kang YJ; Jo JO; Kim HY; Oh YR; Kim YO; Jung MH; Ock MS; Cha HJ
Pathol Oncol Res; 2011 Sep; 17(3):493-502. PubMed ID: 21213129
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells.
Nishi H; Sasaki T; Nagamitsu Y; Terauchi F; Nagai T; Nagao T; Isaka K
Oncol Rep; 2016 Feb; 35(2):992-8. PubMed ID: 26718775
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients.
Dales JP; Garcia S; Meunier-Carpentier S; Andrac-Meyer L; Haddad O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Cancer; 2005 Sep; 116(5):734-9. PubMed ID: 15849727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]